Ettevõttest StandardX
StandardX arendab kompaktset ja suure võimsusega osakestekiirendi platvormi, millega saab toota eri isotoope ühesuguse paigaldise abil. 2025. aastal asutatud ettevõte keskendub alguses isotoopide tarnimisele vähi diagnoosimiseks ja raviks, teadustööks ning tulevaste tuumasünteesisüsteemide jaoks.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.